(4-fluoro-3-methoxyphenyl)boronic acid

Product Information

Molecular Formula:
C7H8BFO3
Molecular Weight:
169.95
Description
(4-fluoro-3-methoxyphenyl)boronic acid is a pharmaceutical intermediate known for its role in the synthesis of many experimental drugs. It has been used to develop targeted cancer therapies and drugs for neurodegenerative diseases.
Synonyms
(4-fluoro-3-methoxyphenyl)boronic acid; 4-Fluoro-3-methoxybenzeneboronic acid; Boronic acid, (4-fluoro-3-methoxyphenyl)-; 4-fluoro-5-methoxyphenylboronic acid; 3-Methoxy-4-fluorophenylboronic acid; B-(4-Fluoro-3-methoxyphenyl)boronic acid; Boronic acid, B-(4-fluoro-3-methoxyphenyl)-; 3-Methoxy4-fluorophenylboronic acid; (4-fluoro-3-methoxyphenyl)boronicacid; 4-fluoro-3-methoxyphenyl boronic acid; (4-fluoro-3-methoxyphenyl)boronic acid
IUPAC Name
(4-fluoro-3-methoxyphenyl)boronic acid
Canonical SMILES
B(C1=CC(=C(C=C1)F)OC)(O)O
InChI
InChI=1S/C7H8BFO3/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,10-11H,1H3
InChI Key
LUJMSRVFSBMEOY-UHFFFAOYSA-N
Flash Point
Not applicable

Safety Information

Hazards
H302 - H319
Precautionary Statement
P305 + P351 + P338

Computed Properties

Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
170.0550524 g/mol
Monoisotopic Mass
170.0550524 g/mol
Topological Polar Surface Area
49.7Ų
Heavy Atom Count
12
Formal Charge
0
Complexity
145
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
CN-113603708-A Preparation method and application of novel CDK9 inhibitor with macrocyclic framework structure 2021-07-27
CN-112939923-A Organic photochromic compound and preparation method and application thereof 2021-01-18
US-2022040336-A1 Heterobiaryl compounds and imaging agents for imaging huntingtin protein 2020-08-06
WO-2022026892-A1 Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers 2020-07-31
WO-2021203010-A1 Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd) 2020-04-03
WO-2021203023-A1 Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) 2020-04-03
WO-2021203025-A1 1 h-pyrazolo[4,3-g]isoquinoline and 1 h-pyrazolo[4,3-g]quinoline derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) 2020-04-03
WO-2021175270-A1 Novel hpk1 inhibitor, preparation method therefor and application thereof 2020-03-03
US-2020361939-A1 Modulators of alpha-1 antitrypsin 2019-05-14
WO-2020117961-A1 Morpholinyl, piperazinyl, oxazepanyl and diazepanyl o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors 2018-12-05
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket